Zevra Therapeutics Prices $60M Public Offering Of 9,230,770 Common Shares At $6.50/Share
Portfolio Pulse from Benzinga Newsdesk
Zevra Therapeutics has announced a $60 million public offering of 9,230,770 common shares at $6.50 per share. The offering is expected to close on August 12, 2024, pending customary closing conditions.
August 09, 2024 | 5:12 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Zevra Therapeutics has announced a $60 million public offering of 9,230,770 common shares at $6.50 per share. The offering is expected to close on August 12, 2024, pending customary closing conditions.
The announcement of a public offering typically leads to a short-term decrease in stock price due to dilution of existing shares. Investors may react negatively to the increased supply of shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100